American Renal Associates Holdings Inc (ARA) Shares Sold by TimesSquare Capital Management LLC

TimesSquare Capital Management LLC lessened its position in American Renal Associates Holdings Inc (NYSE:ARA) by 6.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,053,100 shares of the company’s stock after selling 77,200 shares during the quarter. TimesSquare Capital Management LLC’s holdings in American Renal Associates were worth $18,324,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the stock. Thrivent Financial For Lutherans purchased a new stake in shares of American Renal Associates in the 4th quarter valued at $478,000. Altrinsic Global Advisors LLC raised its holdings in shares of American Renal Associates by 30.0% in the 4th quarter. Altrinsic Global Advisors LLC now owns 130,000 shares of the company’s stock valued at $2,262,000 after buying an additional 30,000 shares during the period. Martingale Asset Management L P raised its holdings in shares of American Renal Associates by 13.9% in the 4th quarter. Martingale Asset Management L P now owns 76,225 shares of the company’s stock valued at $1,327,000 after buying an additional 9,307 shares during the period. Citadel Advisors LLC raised its holdings in shares of American Renal Associates by 306.8% in the 4th quarter. Citadel Advisors LLC now owns 54,254 shares of the company’s stock valued at $944,000 after buying an additional 40,917 shares during the period. Finally, BlackRock Inc. raised its holdings in shares of American Renal Associates by 6.2% in the 4th quarter. BlackRock Inc. now owns 630,825 shares of the company’s stock valued at $10,977,000 after buying an additional 37,034 shares during the period. Hedge funds and other institutional investors own 91.64% of the company’s stock.

How to Become a New Pot Stock Millionaire

Shares of American Renal Associates Holdings Inc (NYSE ARA) opened at $22.33 on Monday. The company has a quick ratio of 1.17, a current ratio of 1.20 and a debt-to-equity ratio of 4.28. The stock has a market capitalization of $702.52, a price-to-earnings ratio of 37.85, a P/E/G ratio of 1.50 and a beta of 2.08. American Renal Associates Holdings Inc has a 1-year low of $9.91 and a 1-year high of $24.07.

American Renal Associates (NYSE:ARA) last issued its quarterly earnings results on Tuesday, March 6th. The company reported $0.18 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.15 by $0.03. American Renal Associates had a positive return on equity of 14.51% and a negative net margin of 1.00%. The company had revenue of $194.40 million for the quarter, compared to the consensus estimate of $195.15 million. During the same quarter in the prior year, the business earned $0.26 EPS. American Renal Associates’s revenue was down 2.5% on a year-over-year basis. research analysts forecast that American Renal Associates Holdings Inc will post 0.74 earnings per share for the current fiscal year.

ARA has been the topic of several research analyst reports. Zacks Investment Research upgraded American Renal Associates from a “hold” rating to a “buy” rating and set a $13.00 price objective on the stock in a report on Thursday, November 16th. Leerink Swann reiterated an “outperform” rating and issued a $17.00 price objective (down previously from $22.00) on shares of American Renal Associates in a report on Tuesday, November 21st. Finally, SunTrust Banks set a $20.00 price objective on American Renal Associates and gave the company a “buy” rating in a report on Thursday, December 21st.

TRADEMARK VIOLATION WARNING: “American Renal Associates Holdings Inc (ARA) Shares Sold by TimesSquare Capital Management LLC” was published by Markets Daily and is the sole property of of Markets Daily. If you are viewing this report on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The legal version of this report can be accessed at https://www.themarketsdaily.com/2018/03/12/american-renal-associates-holdings-inc-ara-shares-sold-by-timessquare-capital-management-llc.html.

American Renal Associates Profile

American Renal Associates Holdings, Inc is a dialysis service provider in the United States focused on joint venture (JV) partnerships with physicians. As of December 31, 2016, the Company owned and operated 214 dialysis clinics in partnership with 379 nephrologist partners treating over 14,000 patients in 25 states and the District of Columbia.

Want to see what other hedge funds are holding ARA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Renal Associates Holdings Inc (NYSE:ARA).

Institutional Ownership by Quarter for American Renal Associates (NYSE:ARA)

Receive News & Ratings for American Renal Associates Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Renal Associates and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply